• Mayo Clinic Researchers Challenge Sepsis Theory
    A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis -- a condition in which the body’s cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells. The Mayo ...More
    February 8, 2006 Posted in News
  • Market for Needle-Free Injection Devices and Safety Syringes to Shoot Up to $2.49 Billion by 2009
    NEW YORK -- With continuing incidences of needlestick injuries in the worldwide healthcare environment and high consumer demand for syringe alternatives, the market for needle-free injection systems and safety syringes is soaring-with some sectors growing in excess of 20 ...More
    February 7, 2006 Posted in News
  • HIV Subtype Predicts Likelihood of Early Death from AIDS
    Johns Hopkins scientists say an infected person’s HIV subtype is a better predictor than viral load for determining rapid death from AIDS. Traditional testing standards help monitor the progression of an HIV infection to AIDS by keeping track of viral load, using a scale in ...More
    February 6, 2006 Posted in News
  • Gut Protein Found to Protect Against Infection, Intestinal Breakdown
    A protein that binds to bile in the small intestine may hold the key to preventing infection and intestinal breakdown in people with conditions such as obstructive jaundice or irritable bowel syndrome, researchers at UT Southwestern Medical Center have discovered. “What ...More
    February 6, 2006 Posted in News
  • Most Common Hepatitis C Virus Type Grown in Lab for First Time
    Researchers at the University of Texas Medical Branch at Galveston (UTMB) have successfully grown the most common and damaging form of the hepatitis C virus in human liver cell cultures. This achievement — the first laboratory cultivation of a “genotype 1” hepatitis C virus ...More
    February 6, 2006 Posted in News
  • FDA Approves New Laboratory Test to Detect Human Infections With Avian Influenza A/H5 Viruses
    HHS' Food and Drug Administration (FDA) today announced the approval of a new laboratory test to diagnose H5 strains of influenza in patients suspected to be infected with the virus. The test was developed by another HHS agency, the Centers for Disease Control and ...More
    February 6, 2006 Posted in News
  • FDA Orders Biomedical Tissue Services, Ltd., to Cease Manufacturing
    Under its comprehensive framework for ensuring the safety of human tissue products, the U.S. Food and Drug Administration (FDA) today ordered Biomedical Tissue Services, Ltd. (BTS), of Fort Lee, N.J., a human tissue-recovery firm, and its CEO and executive director of ...More
    February 6, 2006 Posted in News
  • sanofi pasteur Delivers More H5N1 Vaccine for U.S. Pandemic Initiatives
    SWIFTWATER, Pa. and LYON, France -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group, has delivered more H5N1 vaccine to the U.S. government including investigational doses formulated with an adjuvant. Sanofi pasteur has shipped to the U.S. National ...More
    February 6, 2006 Posted in News
  • HHS and Institut Pasteur Partner on Pandemic Influenza Preparedness
    PARIS -- The U.S. Department of Health and Human Services (HHS) and Institut Pasteur (IP) today agreed to carry out joint activities, beginning in southeast Asia, to strengthen global capacity to detect influenza viruses that could have the potential to trigger a human ...More
    February 6, 2006 Posted in News
  • The Long Research Road to a New Vaccine
    The Food and Drug Administration (FDA) today announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year. The vaccine, developed by Merck ...More
    February 6, 2006 Posted in News